LIEFF CABRASER HEIMANN & BERNSTEIN, LLP


Associated tags: LLP, Patient, Fraud, Patent, Privacy, Social justice, Environment, Professional Services, Legal, Class Action Lawsuit, News, Cryptocurrency, NYSE

Locations: AFRICA, LOS ANGELES, OHIO, UTAH, TENNESSEE, NORTH CAROLINA, NEW YORK, CALIFORNIA, UNITED STATES, NORTH AMERICA, VIRGIN ISLANDS, PUERTO RICO, SAN FRANCISCO

Lieff Cabraser Partner Brendan Glackin Announces $700 Million Settlement with Google over Play Store Misconduct

Retrieved on: 
Tuesday, December 19, 2023

This settlement strikes a blow for competition.”

Key Points: 
  • This settlement strikes a blow for competition.”
    The attorneys general retained Glackin in 2021 as Lead Trial Counsel for the case.
  • Under the terms of the settlement, Google will pay $630 million in restitution, minus costs and fees, to consumers who made purchases on the Google Play Store between August 2016 and September 2023.
  • Play Store consumers will receive automatic payments through PayPal or Venmo, or they can elect to receive a check or ACH transfer.
  • Allow the installation of third-party apps on Android phones from outside the Google Play Store for at least seven years.

Lieff Cabraser and Nigh Goldenberg Announce the Filing of a Personal Injury Lawsuit Against Uber Technologies Inc. for Harassment, Attack, Sexual Assault, and Battery by Uber Driver

Retrieved on: 
Thursday, September 28, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP and Washington, D.C. firm Nigh Goldenberg Raso & Vaughn have filed a federal personal injury lawsuit on behalf of Doe Plaintiff "M.F.A."

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP and Washington, D.C. firm Nigh Goldenberg Raso & Vaughn have filed a federal personal injury lawsuit on behalf of Doe Plaintiff "M.F.A."
  • against Uber Technologies and related entities alleging harassment, physical attack, sexual assault, and battery committed by a vetted Uber driver in June of 2023.
  • “The plaintiff in this injury lawsuit trusted Uber and its highly-publicized safety protections for a simple two-stop ride,” notes Lieff Cabraser partner Sarah R. London, who represents M.F.A.
  • “That trust was betrayed in a shocking and profound violation of trust and her personal safety and well-being.

Lieff Cabraser & Cowan, DeBaets File Federal Class Action Copyright Infringement Suit in New York District Court Against OpenAI on Behalf of Authors Guild and Professional Authors

Retrieved on: 
Wednesday, September 20, 2023

The suit includes claims for direct copyright infringement under 17 U.S.C.

Key Points: 
  • The suit includes claims for direct copyright infringement under 17 U.S.C.
  • section 501 as well as vicarious and contributory copyright infringement, and injunctive relief in the form of a fair licensing regime as well as statutory and other damages.
  • “Without plaintiffs’ and the proposed class’ copyrighted works, Defendants would have a vastly different commercial product,” notes Lieff Cabraser partner Rachel Geman, Co-Counsel for Plaintiffs and the Proposed Class.
  • Defendants could have ‘trained’ their large language models on works in the public domain or paid a reasonable licensing fee to use copyrighted works.”

Equal Rights Advocates and Lieff Cabraser Announce Class Action Lawsuit by Women Vassar Professors Over College’s Gender Pay Gap

Retrieved on: 
Wednesday, August 30, 2023

As classes began this week, most of the women full professors at Vassar College spoke out about long-standing pay discrimination, culminating in their filing today of a class action lawsuit.

Key Points: 
  • As classes began this week, most of the women full professors at Vassar College spoke out about long-standing pay discrimination, culminating in their filing today of a class action lawsuit.
  • Vassar is one of the Seven Sisters, a group of historically women’s colleges founded on the promise of gender equity.
  • According to the professors, average salary data reflect a gender pay gap at Vassar in every year for the last two decades.
  • Most troublingly, the professors allege this gap has grown over time, with the most recent data reflecting a 10 percent gender pay disparity at Vassar.

RTX Investors: 10/2/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Tuesday, August 29, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) who suffered losses from purchasing or otherwise acquiring RTX securities (NYSE: RTX) between February 8, 2021 and July 25, 2023 to contact us immediately regarding a pending securities fraud class action against RTX.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) who suffered losses from purchasing or otherwise acquiring RTX securities (NYSE: RTX) between February 8, 2021 and July 25, 2023 to contact us immediately regarding a pending securities fraud class action against RTX.
  • The deadline to apply to be lead plaintiff is October 2, 2023.
  • RTX is an aerospace and defense company which owns Pratt & Whitney, a producer of aircraft engines, including the PW1000G Turbofan (“GTF”) engine family.
  • On July 25, 2023, RTX issued a press release stating that Pratt & Whitney discovered a condition in the powdered metal used to manufacture GTF engines, which will require accelerated removals and inspections of the engine family.

RTX Investors: October 2, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Monday, August 28, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) who suffered losses from purchasing or otherwise acquiring RTX securities (NYSE: RTX) between February 8, 2021 and July 25, 2023 to contact us immediately regarding a pending securities fraud class action against RTX.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) who suffered losses from purchasing or otherwise acquiring RTX securities (NYSE: RTX) between February 8, 2021 and July 25, 2023 to contact us immediately regarding a pending securities fraud class action against RTX.
  • The deadline to apply to be lead plaintiff is October 2, 2023.
  • RTX is an aerospace and defense company which owns Pratt & Whitney, a producer of aircraft engines, including the PW1000G Turbofan (“GTF”) engine family.
  • On July 25, 2023, RTX issued a press release stating that Pratt & Whitney discovered a condition in the powdered metal used to manufacture GTF engines, which will require accelerated removals and inspections of the engine family.

SentinelOne Investors: 8/7/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Thursday, July 27, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in SentinelOne, Inc. (“SentinelOne” or the “Company”) who suffered losses from purchasing or otherwise acquiring SentinelOne securities (NYSE: S) between June 1, 2022 and June 1, 2023 to contact us immediately regarding pending securities fraud class action against SentinelOne.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in SentinelOne, Inc. (“SentinelOne” or the “Company”) who suffered losses from purchasing or otherwise acquiring SentinelOne securities (NYSE: S) between June 1, 2022 and June 1, 2023 to contact us immediately regarding pending securities fraud class action against SentinelOne.
  • The deadline to apply to be a lead plaintiff is August 7, 2023.
  • SentinelOne is a cybersecurity company purporting to have developed the first AI-powered Extended Detection and Response platform to render cybersecurity defense actually autonomous.
  • On this news, the price of SentinelOne’s stock fell $7.28 per share, or 35.14%, from a closing price of $20.72 on June 1, 2023, to close at $13.44 per share on June 2, 2023, on extremely elevated trading volume.

SentinelOne Investors: August 7, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Tuesday, July 25, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in SentinelOne, Inc. (“SentinelOne” or the “Company”) who suffered losses from purchasing or otherwise acquiring SentinelOne securities (NYSE: S) between June 1, 2022 and June 1, 2023 to contact us immediately regarding pending securities fraud class action against SentinelOne.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in SentinelOne, Inc. (“SentinelOne” or the “Company”) who suffered losses from purchasing or otherwise acquiring SentinelOne securities (NYSE: S) between June 1, 2022 and June 1, 2023 to contact us immediately regarding pending securities fraud class action against SentinelOne.
  • The deadline to apply to be a lead plaintiff is August 7, 2023.
  • SentinelOne is a cybersecurity company purporting to have developed the first AI-powered Extended Detection and Response platform to render cybersecurity defense actually autonomous.
  • On this news, the price of SentinelOne’s stock fell $7.28 per share, or 35.14%, from a closing price of $20.72 on June 1, 2023, to close at $13.44 per share on June 2, 2023, on extremely elevated trading volume.

NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Monday, July 3, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us immediately regarding pending securities fraud class action against NovoCure.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us immediately regarding pending securities fraud class action against NovoCure.
  • The deadline to apply to be a lead plaintiff is August 18, 2023.
  • NovoCure, headquartered in the Bailiwick of Jersey, is an oncology company with a proprietary technology called Tumor Treating Fields (“TTFields”) that exert physical forces to kill cancer cells through various mechanisms.
  • NovoCure conducted a study, called LUNAR, that aimed to evaluate TTFields’ effectiveness in treating non-small cell lung cancer, along with standard therapies.

NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Thursday, June 29, 2023

National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us immediately regarding pending securities fraud class action against NovoCure.

Key Points: 
  • National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us immediately regarding pending securities fraud class action against NovoCure.
  • The deadline to apply to be a lead plaintiff is August 18, 2023.
  • NovoCure, headquartered in the Bailiwick of Jersey, is an oncology company with a proprietary technology called Tumor Treating Fields (“TTFields”) that exert physical forces to kill cancer cells through various mechanisms.
  • NovoCure conducted a study, called LUNAR, that aimed to evaluate TTFields’ effectiveness in treating non-small cell lung cancer, along with standard therapies.